Drug
Acetyldigitoxin
Acetyldigitoxin: highest development phase Approved, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACYLANID | Approved |
Latest
No recent events.
Follow Acetyldigitoxin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.